羅浩倫 主任
學歷
現職
長庚醫院泌尿科主任
長庚醫院臨床試驗中心副主任
台灣泌尿腫瘤醫學會理事
經歷
- 2010-2011 高雄長庚醫院泌尿科研究員
- 2012-2013 高雄長庚醫院泌尿科主治醫師
- 2013-2015 高雄長庚醫院泌尿科學術組講師
- 2016-2021 高雄長庚醫院泌尿科學術組助理教授
- 2021-now 高雄長庚醫院泌尿科學術副教授
專長
- 泌尿腫瘤手術
- 腹腔鏡及微創手術
- 無痛結紮
- 性功能復健療程
榮譽
國際醫學會邀請演講
2007年高雄長庚醫院執業至今發表18篇學術論文如下:
- Chien CS, Luo HL, Ling CS, Chiang PH, Chen YT*, Cheng YT*. Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan. Int Urol Nephrol. 2016 May 18(SCI; IF=1.519; Urology and Nephrology 46/78)
- Luo HL, Sung MT, Tsai EM, Lin CS, Lee NL, Chung YH, Chiang PH*. Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features. Sci Rep. 2016 Apr 7;6:24263. (SCI; IF=5.578; Multidisciplinary Sciences 5/57)
- Hsu LN, Lin SE, Luo HL, Chang JC, Chiang PH*. Double-barreled Colon Conduit and Colostomy for Simultaneous Urinary and Fecal Diversions: Long-term Follow-up. Ann Surg Oncol. 2014. 21 Suppl 4:522-7. (SCI; IF=4.166; Surgery 9/199)。
- Luo HL, Chen YT, Chuang YC, Cheng YT, Lee WC, Kang CH, Chiang PH*. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome. BJU Int. 2014. 113:E144-9. (SCI; IF=3.046; Urology and Nephrology 15/73)。
- Hung SY, Yang WC*, Luo HL, Hsu CC, Chen YT, Chuang YC. Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer. Int Urol Nephrol. 2014. 46:921-6. (SCI; IF=1.471; Urology and Nephrology 47/73)。
- Luo HL, Kang CH, Chen YT, Chuang YC, Cheng YT, Lee WC, Chiang PH*. Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location. Int J Urol. 2014. 21:366-9. (SCI; IF=1.734; Urology and Nephrology 35/73)
- Luo HL, Kang CH, Chen YT, Chuang YC, Lee WC, Cheng YT, Chiang PH*. Diagnostic Ureteroscopy Independently Correlates with Intravesical Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma. Ann Surg Oncol. 2013. 20:3121-6. (SCI; IF=4.166; Surgery 9/199)。
- Luo HL, Kang CH, Chen YT, Chuang YC, Lee WC, Cheng YT, Chiang PH*. Severity of Hydronephrosis Correlates with Tumor Invasiveness and Urinary Bladder Recurrence of Ureteral Cancer. BJU Int. 2013. 112:489-94. (SCI; IF=3.046; Urology and Nephrology 15/73)。
- Luo HL, Tsai KL, Lin SE, Chiang PH*. Outcome of urinary bladder recurrence after partial cystectomy for en bloc urinary bladder adherent colorectal cancer resection. Int J Colorectal Dis. 2013. 28: 631-5. (SCI; IF=2.385; Surgery 47/199)。
- Luo HL, Fang FM, Kang CH, Chuang YC, Chiang PH*.Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate? Int Urol Nephrol. 2013. 45:113-9. (SCI; IF=1.471; Urology and Nephrology 47/73)。
- Luo HL, Chen YT, Chiang PH*.Re: EvanguelosXylinas, Michael Rink, Eugene K. Cha, et al. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur Urol. 2012. 62:e92-e93. (SCI; IF=8.493; Urology and Nephrology 2/73)。
- Luo HL, Chen YT, Chiang PH*. Re: Xiao-Dong Jin, Simone Roethlisberger, Fiona C.Burkhard, Fre’de’ ricBirkhaeuser, Harriet C. Thoeny, Urs. E. Studer. Long-term Renal Function After Urinary Diversion by Ileal Conduit or OrthotopicIleal Bladder Substitution. Eur Urol. 2012. 62:e43-e44. (SCI; IF=8.493; Urology and Nephrology 2/73)。
- Luo HL, Chiang PH*, Chen YT, Cheng YT. Lymphovascular invasion is a pathological feature related to aggressive cancer behavior and predicts early recurrence in prostate cancer. Kaohsiung J Med Sci. 2012; 28:327-30. (SCI; IF=0.477; MEDICINE, RESEARCH & EXPERIMENTAL 97/111)。
- Chiang PH*, Luo HL, Chen YT, Kang CH, Chuang YC, Lee WC.Is hand-assisted retroperitoneoscopic nephroureterectomy better than transurethral bladder cuff incision-assisted nephroureterectomy?J Endourol. 2011; 25:1307-13. (Co-first author)(SCI; IF=1.847; Urology and Nephrology 35/73)。
- Wang HJ, Lee TY, Luo HL, Chen CH, Shen YC, Chuang YC, Chiang PH*.Application of resonance metallic stents for ureteral obstruction.BJU Int. 2011; 108:428-32.(SCI; IF=2.884; Urology and Nephrology 19/73)。
- Cheng YT, Luo HL, Sung MT, Chiang PH*.:Micropapillary variant of urothelial carcinoma: a report of 4 cases and literature review.Chang Gung Med J. 2010; 33:461-5.
- Luo HL, Fang FM, Chuang YC, Chiang PH*.:Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer. BJU Int. 2009; 104:1620-3.(SCI; IF=2.884; Urology and Nephrology 19/73)。
- Luo HL, Kang CH, Chiang PH*.:Gasless hand-assisted retroperitoneoscopic nephroureterectomy. J Endourol. 2009;23:69-74. (SCI; IF=1.847; Urology and Nephrology 35/73)。
國際會議學術論文發表:
- Luo HL. Gasless hand assisted retroperitoneoscopic nephroureterectomy. 26th World Congress of Endourology & SWL. 2008/12/1.
- Luo HL. Gender specific age effect for upper urinary tract urothelial carcinoma. Geriatric Urology Society_AUA annual meeting, Orlando, United States. 2014/05/18.
- Luo HL. Urinary Retention Is a Potential Pitfall in Postoperative Renal Function Care of Patients with Ileal Neobladder Reconstruction.34th Congress of Society International Urology, Glasgow, UK. 2014/10/12.
- Luo HL. Proposal of Routine Percutaneous Drainage for Emphysematous Pyelonephritis: Evidence from Single Institutional Experience and Systemic Review. 34th Congress of Society International Urology, Glasgow, UK. 2014/10/12.